CSL Behring
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas.
SCID research paper explores types of uncertainty faced by parents
Remember The Girls empowers women affected by X-linked conditions
Leniolisib approved for treating ultrarare APDS 1 and 2
PI education kit for schools
Project ECHO clinician series: Signs and symptoms of PI
Lunch & Learn: What is chimerism?
Healing the trauma of a life-changing PI diagnosis
Prophylactic antibiotics and PI

